STVN Stock Analysis: Buy, Sell, or Hold?
STVN - Stevanato Group S.p.A.
$22.60
0.25 (1.12%)
▲
5d:
+7.31%
30d:
+16.49%
90d:
+26.61%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When STVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: STVN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: STVN shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$32.29
Based on 11.8% avg growth
INTRINSIC VALUE TODAY
$20.05
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STVN is currently trading at $22.60, which is considered extended relative to its 30-day fair value range of $19.42 to $21.31. From a valuation perspective, the stock is trading at a premium (Forward PE: 25.7) compared to its historical average (22.3). At these levels, the market is pricing in 5.0% annual earnings growth.
Technical Outlook: Technically, STVN is in a strong uptrend. The price is approaching resistance at $22.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: STVN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $25.10 (+16.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, STVN is in a strong uptrend. The price is approaching resistance at $22.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: STVN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $25.10 (+16.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$19.42 -
$21.31
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
24.8%
All Signals
- BEARISH: Price extended above range (+6.1% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($25.10)
- BULLISH: Expecting earnings turnaround to 5.0% growth with 7.8% revenue growth
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$19.42 -
$21.31
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$19.99
Resistance Level
$22.68
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.74
Wall Street Target
$25.10
(+16.6%)
Revenue Growth (YoY)
7.8%
Earnings Growth (YoY)
-26.5%
Profit Margin
11.0%
Valuation Premium vs History
+5.0% premium
PE vs Historical
25.7 vs 22.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.0%
(market-implied from PE analysis)
1-Year Target
$22.60
(+5%)
2-Year Target
$23.73
(+10%)
3-Year Target
$24.91
(+16%)
3-Yr Target (if PE normalizes)
(PE: 26→22)
PE COMPRESSION
$21.58
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.7, Growth: 19.5%)
$36.74
(+71%)
Base:
(SPY PE: 20.2, Growth: 19.5%)
$28.87
(+34%)
Bear:
(PE: 17.2, Growth: 19.5%)
$24.54
(+14%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (37x PE), but valuation improves significantly next year (26x PE) as earnings recover.
Trailing PE: 37.28 | Current EPS (TTM): $0.57
Bull Case
$34.28
(+52%)
Analyst growth 46.6%, PE expands to 41.0
Base Case
$31.16
(+38%)
Market implied 46.6%, PE stable at 37.3
Bear Case
$14.45
(-36%)
Severe decline -20.0%, PE contracts to 31.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 22, 2026 8:02 PM ET
Data refreshes hourly during market hours. Next update: 9:02 PM
Data refreshes hourly during market hours. Next update: 9:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 46 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$86 | 37 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 66 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$247 | 41 HOLD |
